Skip to content

Retinitis Pigmentosa 92 C5562022

Published: July 22, 2026Updated: August 20, 2026

An inherited retinal disease causing gradual vision loss as light-sensing cells deteriorate. No cure exists, but low vision aids and genetic testing can help patients adapt.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Progressive visual field constriction

!

Decreased central visual acuity

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness

(ophthalmologic)

Vitreoretinal interface abnormalities

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular Ophthalmologic Monitoring

Comprehensive eye examinations including visual field testing, electroretinography, and retinal imaging to track disease progression and adjust management strategies.

monitoring
3

Vitamin A Supplementation

Oral vitamin A palmitate supplementation has been shown to slow photoreceptor degeneration in some RP patients. Regular monitoring of liver function and serum vitamin A levels is essential.

dietary

Additional treatment options

Low Vision Rehabilitation

Training in use of low vision aids, magnifiers, and adaptive technologies to maximize remaining vision and maintain independence in daily activities.

lifestyle

Retinal Prosthesis Evaluation

Assessment for Argus II retinal implant candidacy for patients with advanced RP. The electronic device partially restores visual perception through direct retinal stimulation.

surgical

Vision Loss Counseling

Individual and group therapy addressing depression, anxiety, and adjustment to progressive vision loss. Focus on coping strategies and quality of life preservation.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 92 C5562022?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sankar MJ, Ng PC, Buist K, et al. Clinical Practice Guidelines for Inherited Retinal Dystrophies Including Retinitis Pigmentosa. Ophthalmology. 2022.

guideline2022View source →
2

Hamel CP, Bocquet B, Audo I. Gene Therapy for Retinitis Pigmentosa: Current Progress and Future Directions. Surv Ophthalmol. 2021.

review2021View source →
3

Cideciyan AV, Roman MI, McGuigan DB, et al. Phase I/II Clinical Trial of Vectored Gene Therapy for RPE65-Associated Retinal Dystrophy. JAMA Ophthalmol. 2020.

clinical_trial2020View source →
4

Chen TC, Huang DS, Wu CY, Lin HY. Nutritional and Antioxidant Interventions in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis. Prog Retin Eye Res. 2023.

meta_analysis2023View source →

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 92 C5562022. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy